(MENAFNEditorial) iCrowdNewswire - Aug 28, 2017
"Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness."
Scope of the Report:
This report focuses on in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
For Requesting a Sample Copy of This Report, Please Visit @
Market Segment by Manufacturers, this report covers
- Pfizer
- Mylan
- Novartis
- Apotex
- Teva
- Taj Pharma
- CR Zizhu
Market Segment by Regions, regional analysis covers
- North America (USA, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Columbia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Open-angle Glaucoma
- Close-angle Glaucoma
There are 15 Chapters to deeply display the global Latanoprost market.
Chapter 1, to describe Latanoprost Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Latanoprost, with sales, revenue, and price of Latanoprost, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Latanoprost, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Latanoprost market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Latanoprost sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Browse Full Table of Contents and Report Description @
Table of Contents
7 Asia-Pacific Latanoprost by Countries
7.1 Asia-Pacific Latanoprost Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Latanoprost Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Latanoprost Revenue by Countries (2012-2017)
7.2 China Latanoprost Sales and Growth (2012-2017)
7.3 Japan Latanoprost Sales and Growth (2012-2017)
7.4 Korea Latanoprost Sales and Growth (2012-2017)
7.5 India Latanoprost Sales and Growth (2012-2017)
7.6 Southeast Asia Latanoprost Sales and Growth (2012-2017)
8 South America Latanoprost by Countries
8.1 South America Latanoprost Sales, Revenue and Market Share by Countries
8.1.1 South America Latanoprost Sales by Countries (2012-2017)
8.1.2 South America Latanoprost Revenue by Countries (2012-2017)
8.2 Brazil Latanoprost Sales and Growth (2012-2017)
8.3 Argentina Latanoprost Sales and Growth (2012-2017)
8.4 Columbia Latanoprost Sales and Growth (2012-2017)
9 Middle East and Africa Latanoprost by Countries
9.1 Middle East and Africa Latanoprost Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Latanoprost Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Latanoprost Revenue by Countries (2012-2017)
9.2 Saudi Arabia Latanoprost Sales and Growth (2012-2017)
9.3 UAE Latanoprost Sales and Growth (2012-2017)
9.4 Egypt Latanoprost Sales and Growth (2012-2017)
9.5 Nigeria Latanoprost Sales and Growth (2012-2017)
9.6 South Africa Latanoprost Sales and Growth (2012-2017)
About Us
Reports Monitor (ReportsMonitor.com) is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. We have a vast collection of reports, covering maximum industries worldwide. Our process is meticulously planned and executed in order to use maximum resources and explore the market for getting genuine insights. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.
MENAFN2808201700703403ID1095782767